TEVA $241M net lose ( GAAP). gross profit reduced sharply, By 27%. Another red flag is TEVA's flag product Copaxone. Sales collapsed by 46%. I recommended it at around $17, but recently warned about it's future: ash: "TEVA Bonds - real concern. Moody’s Downgrades Teva Bond Rating to “Junk”. Teva’s Credit Rating also Cut to Junk by Fitch".
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.